GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Selling and Marketing Expense

Belluscura (FRA:9VQ) Selling and Marketing Expense : €1.06 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Belluscura's Selling and Marketing Expense for the six months ended in Jun. 2023 was €0.25 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 was €1.06 Mil.

Belluscura Selling and Marketing Expense Historical Data

The historical data trend for Belluscura's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Selling and Marketing Expense Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Selling and Marketing Expense
- - - 0.99 1.34

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only 0.08 0.91 0.54 0.81 0.25

Belluscura Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Belluscura's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Selling and Marketing Expense
Comparable Companies
LSE:IUG LSE:IHC LSE:POLX LSE:SUN LSE:MHC LSE:DEMG LSE:RUA LSE:CREO LSE:EKF ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN
Traded in Other Exchanges
BELL:UK
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Website
https://www.belluscura.com
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines